机译:噻托溴铵联合安慰剂,沙美特罗或氟替卡松-沙美特罗治疗慢性阻塞性肺疾病:一项随机试验
From The Ottawa Health Research Institute and University of Ottawa, Ottawa, Ontario, Canada;
The University of Toronto, Toronto, Ontario, Canada;
McMaster University, Hamilton, Ontario, Canada;
Queen's University, Kingston, Ontario, Canada;
Scarborough Centenary Hospital, Scarborough, Ontario, Canada;
University of Western Ontario, London, Ontario, Canada;
St. Lawrence Medical Clinic, Morrisburg, Ontario, Canada;
University of British Columbia, Vancouver, British Columbia, Canada;
Centre de Recherche, Hôpital Laval, Université Laval, Québec, Québec, Canada;
McGill University, Montréal, Québec, Canada;
Dalhousie University, Halifax, Nova Scotia, Canada;
University of Manitoba, Winnipeg, Manitoba, Canada;
University of New Brunswick, St. John, New Brunswick, Canada;
University of Saskatchewan, Saskatoon, Saskatchewan, Canada;
University of Calgary, Calgary, Alberta, Canada;
University of Alberta, Edmonton, Alberta, Canada;
Memorial University, St. John's, Newfoundland, Canada;
and The Woolcock Institute of Medical Research, Sydney, Australia.;
机译:噻托溴铵联合安慰剂,沙美特罗或氟替卡松-沙美特罗治疗慢性阻塞性肺疾病:戒断治疗的可能混杂影响?
机译:噻托溴铵联合安慰剂,沙美特罗或氟替卡松-沙美特罗治疗慢性阻塞性肺疾病:戒断治疗的可能混杂影响?
机译:单独启动噻托尼亚与脱硼酸盐/萨尔梅托尔联合治疗的脱噻吩及慢性阻塞性肺病的成本的影响研究
机译:使用LC / MS / MS从等离子体中低水平定量氟酮和唾液测定醇
机译:使用随机森林模型预测慢性阻塞性肺疾病的住院和再住院风险
机译:单独使用噻托铵与噻托溴铵联合丙酸氟替卡松/沙美特罗联合治疗对慢性阻塞性肺疾病的疗效和成本影响的观察性研究
机译:糖藻溴铵+ Salmeterol / Fluticasone和噻托溴铵+ Salmeterol / Fluticasons在慢性阻塞性肺病中的疗效和安全性比较研究